Latest News

Beijing, China – Medullary thyroid carcinoma (MTC) has been the focus of research in the field of thyroid cancer management in the last 20 years along with recurrent laryngeal nerve, according to a new study that analyzed trends in the post-operative management of thyroid cancer between 2003 and 2022. “Future...
MIAMI, FLORIDA – Few standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by excessive scar tissue that disrupts the normal production of blood cells But new research conducted by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and...
CHICAGO, IL – Many cancers caused by the mutation of the BRAF gene respond well to a class of immunotherapies known as BRAF-inhibitors. BRAF-mutated colorectal cancer, however, almost never does. Doctors have known this for years, but they are yet to find a treatment that works well for most patients....
SINGAPORE – Scientists from Duke-NUS Medical School (Duke-NUS) and their collaborators have come up with new methods to cultivate brain cells from stem cells to treat and study neurodegenerative diseases. This novel technology forms the basis of two recent research projects under the newly established GK Goh Centre for Neuroscience...
Seoul, South Korea – Diabetes mellitus and sarcopenia pose a substantial challenge to public health, especially among the elderly. These conditions share common pathophysiological mechanism and are linked bidirectionally, with each contributing to an increased risk of the other. Previous research has shown that both diabetes and sarcopenia are individually...
Short-term treatment with the drug ruxolitinib prevents B-cell acute lymphoblastic leukemia (B-ALL) in mice that have a genetic predisposition to the disease. St. Jude Children’s Research Hospital and the Cancer Research Center in Salamanca, Spain, led the research. The findings appear today in Cancer Research. The work provides the first evidence in an...
Boston, Massachusetts – The Neuroendocrine Tumor Research Foundation celebrates a significant milestone in cancer therapy: a first-in-human CAR T cell therapy clinical trial for neuroendocrine tumors (NETs) will open in 2024. NETRF supported the early-stage, preclinical research that led to the development of this therapy. Chimeric Therapeutics, an Australian leader...
A research in mice has demonstrated how tangles of a so-called tau protein can spread within the brain. Tangled masses of that tau protein contribute to several neurodegenerative diseases – those that destroy brain functions – including Alzheimer’s disease. The research has provided insights into how tau tangles spread that...